An opposite upregulation or non-significant changes were observed for the expression of collagen-degrading Mmp8 (p < 0.01) and Mmp9 (p = 0.995) genes, respectively, both known to play an important role in the inflammation resolution phase of NASH (Fig. 4D). This evidence concerns the gene MMP9 and metabolic dysfunction-associated steatohepatitis.